FDA Drug recall D-0072-2023
Desmopressin Acetate Tablets 0.2mg, 100-count bottles, RX Only, Distributed by: Avet Pharmaceuticals Inc
- FDA Drug
- Class II
- terminated
- Published 2022-12-07
On 2022-12-07 the FDA classified a Class II recall of Desmopressin Acetate Tablets 0.2mg, 100-count bottles, RX Only, Distributed by: Avet Pharmaceuticals Inc by Heritage Pharmaceuticals, citing subpotent Drug.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0072-2023 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2022-11-23 |
| Published | 2022-12-07 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Heritage Pharmaceuticals |
| Distribution | US |
Product
Desmopressin Acetate Tablets 0.2mg, 100-count bottles, RX Only, Distributed by: Avet Pharmaceuticals Inc. East Brunswick, NJ 08816, NDC 23155-490-01
Reason
Subpotent Drug
Identifiers
| ndc | 23155-489-01 |
|---|---|
| ndc | 23155-489-05 |
| ndc | 23155-490-01 |
| ndc | 23155-490-05 |
| code_info | Lot #: 220440A, Exp. Date 05/2024 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0072-2023%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.